{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T06:06:11Z","timestamp":1780380371872,"version":"3.54.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2014,6,26]],"date-time":"2014-06-26T00:00:00Z","timestamp":1403740800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s00259-014-2825-4","type":"journal-article","created":{"date-parts":[[2014,6,25]],"date-time":"2014-06-25T15:58:55Z","timestamp":1403711935000},"page":"2023-2030","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Performance of FDG PET\/CT at initial diagnosis in a rare lymphoma: nodular lymphocyte-predominant Hodgkin lymphoma"],"prefix":"10.1007","volume":"41","author":[{"given":"Jean Fran\u00e7ois","family":"Grellier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Vercellino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Leblanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Merlet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Thieblemont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Weinmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Elisabeth","family":"Toubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Berenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josette","family":"Bri\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Brice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,26]]},"reference":[{"issue":"Suppl 1","key":"2825_CR1","doi-asserted-by":"crossref","first-page":"i54","DOI":"10.1093\/annonc\/mdi814","volume":"16","author":"LM Jost","year":"2005","unstructured":"Jost LM, Stahel RA; ESMO Guidlines Task Force. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of Hodgkin\u2019s disease. Ann Oncol. 2005;16 Suppl 1:i54\u20135.","journal-title":"Ann Oncol"},{"issue":"17","key":"2825_CR2","doi-asserted-by":"crossref","first-page":"9337","DOI":"10.1073\/pnas.94.17.9337","volume":"94","author":"S Braeuninger","year":"1997","unstructured":"Braeuninger S, Kueppers R, Strickler JG, Wacker HH, Rajewsky K, Hansmann ML. Hodgkin and Reed-Sternberg cells in lymphocyte predominance Hodgkin disease represent clonal populations of germinal center derived tumor cells. Proc Natl Acad Sci U S A. 1997;94(17):9337\u201342.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2825_CR3","volume-title":"WHO classification of tumors of hematopoietic and lymphoid tissues","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO classification of tumors of hematopoietic and lymphoid tissues. Lyon: IARC; 2008."},{"issue":"5","key":"2825_CR4","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/00000478-199405000-00014","volume":"18","author":"DY Mason","year":"1994","unstructured":"Mason DY, Banks PM, Chan J, Cleary ML, Delsol G, de Wolf Peeters C, et al. Nodular lymphocyte predominance Hodgkin\u2019s disease: a distinct clinicopathological entity. Am J Surg Pathol. 1994;18(5):526\u201330.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"2825_CR5","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1182\/blood-2003-05-1487","volume":"103","author":"T Marafioti","year":"2004","unstructured":"Marafioti T, Pozzobon M, Hansmann ML, Delsol G, Pileri SA, Mason DY. Expression of intracellular signaling molecules in classical and lymphocyte predominance Hodgkin disease. Blood. 2004;103(1):188\u201393.","journal-title":"Blood"},{"issue":"3","key":"2825_CR6","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/path.1894","volume":"208","author":"C Atayar","year":"2006","unstructured":"Atayar C, Poppema S, Visser L, van den Berg A. Cytokine gene expression profile distinguishes CD4\/CD57 T cells of the nodular lymphocyte predominance type of Hodgkin\u2019s lymphoma from their tonsillar counterparts. J Pathol. 2006;208(3):423\u201330.","journal-title":"J Pathol"},{"issue":"3","key":"2825_CR7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF00390466","volume":"108","author":"ML Hansmann","year":"1984","unstructured":"Hansmann ML, Zwingers T, B\u00f6ske A, L\u00f6ffler H, Lennert K. Clinical features of nodular paragranuloma (Hodgkin\u2019s disease, lymphocyte predominance type, nodular). J Cancer Res Clin Oncol. 1984;108(3):321\u201330.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"2825_CR8","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1002\/1097-0142(19930315)71:6<2062::AID-CNCR2820710622>3.0.CO;2-0","volume":"71","author":"PM Mauch","year":"1993","unstructured":"Mauch PM, Kalish LA, Kadin M, Coleman CN, Osteen R, Hellman S. Patterns of presentation of Hodgkin disease. Implications for etiology and pathogenesis. Cancer. 1993;71(6):2062\u201371.","journal-title":"Cancer"},{"issue":"3","key":"2825_CR9","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1200\/JCO.1999.17.3.776","volume":"17","author":"V Diehl","year":"1999","unstructured":"Diehl V, Sextro M, Franklin J, Hansmann ML, Harris N, Jaffe E, et al. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin\u2019s disease and lymphocyte-rich classical Hodgkin\u2019s disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin\u2019s Disease. J Clin Oncol. 1999;17(3):776\u201383.","journal-title":"J Clin Oncol"},{"issue":"9","key":"2825_CR10","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1200\/JCO.1997.15.9.3060","volume":"15","author":"S Bodis","year":"1997","unstructured":"Bodis S, Kraus MD, Pinkus G, Silver B, Kadin ME, Canellos GP, et al. Clinical presentation and outcome in lymphocyte-predominant Hodgkin\u2019s disease. J Clin Oncol. 1997;15(9):3060\u20136.","journal-title":"J Clin Oncol"},{"issue":"2","key":"2825_CR11","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0360-3016(94)E0136-8","volume":"31","author":"E Crennan","year":"1995","unstructured":"Crennan E, D\u2019Costa I, Liew KH, Thompson J, Laidlaw C, Cooper I, et al. Lymphocyte predominant Hodgkin\u2019s disease: a clinicopathologic comparative study of histologic and immunophenotypic subtypes. Int J Radiat Oncol Biol Phys. 1995;31(2):333\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"2825_CR12","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/oxfordjournals.annonc.a059244","volume":"6","author":"VI Pappa","year":"1995","unstructured":"Pappa VI, Norton AJ, Gupta RK, Wilson AM, Rohatiner AZ, Lister TA. Nodular type of lymphocyte predominant Hodgkin\u2019s disease. A clinical study of 50 cases. Ann Oncol. 1995;6(6):559\u201365.","journal-title":"Ann Oncol"},{"issue":"5","key":"2825_CR13","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1200\/JCO.2009.24.9516","volume":"28","author":"M Al-Mansour","year":"2010","unstructured":"Al-Mansour M, Connors J, Gascoyne R, Skinnider B, Savage KJ. Transformation to aggressive lymphoma in nodular lymphocyte-predominant Hodgkin's lymphoma. J Clin Oncol. 2010;28(5):793\u20139.","journal-title":"J Clin Oncol"},{"issue":"3","key":"2825_CR14","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1148\/radiology.203.3.9169707","volume":"203","author":"F Moog","year":"1997","unstructured":"Moog F, Bangerter M, Diederichs CG, Guhlmann A, Kotzerke J, Merkle E, et al. Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging. Radiology. 1997;203(3):795\u2013800.","journal-title":"Radiology"},{"issue":"10","key":"2825_CR15","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1023\/A:1008486928190","volume":"9","author":"M Bangerter","year":"1998","unstructured":"Bangerter M, Moog F, Buchmann I. Whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin\u2019s disease. Ann Oncol. 1998;9(10):1117\u201322.","journal-title":"Ann Oncol"},{"issue":"5","key":"2825_CR16","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1080\/028418602320405014","volume":"41","author":"C Menzel","year":"2002","unstructured":"Menzel C, D\u00f6bert N, Mitrou P, Mose S, Diehl M, Berner U, et al. Positron emission tomography for the staging of Hodgkin\u2019s lymphoma. Acta Oncol. 2002;41(5):430\u20136.","journal-title":"Acta Oncol"},{"issue":"1","key":"2825_CR17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00277-001-0390-y","volume":"81","author":"MR Weihrauch","year":"2002","unstructured":"Weihrauch MR, Re D, Bischoff S, Dietlein M, Scheidhauer K, Krug B, et al. Whole-body positron emission tomography using 18F-fluorodeoxyglucose for initial staging of patients with Hodgkin\u2019s disease. Ann Hematol. 2002;81(1):20\u20135.","journal-title":"Ann Hematol"},{"issue":"4","key":"2825_CR18","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s11547-008-0264-7","volume":"113","author":"E Pelosi","year":"2008","unstructured":"Pelosi E, Pregno P, Penna D, Deandreis D, Chiappella A, Limerutti G, et al. Role of whole-body [18F] fluorodeoxyglucose positron emission tomography\/computed tomography (FDG-PET\/CT) and conventional techniques in the staging of patients with Hodgkin and aggressive non Hodgkin lymphoma. Radiol Med. 2008;113(4):578\u201390. doi: 10.1007\/s11547-008-0264-7 .","journal-title":"Radiol Med"},{"issue":"5","key":"2825_CR19","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, et al. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007;25(5):579\u201386.","journal-title":"J Clin Oncol"},{"issue":"5","key":"2825_CR20","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1200\/JCO.2006.08.2305","volume":"25","author":"ME Juweid","year":"2007","unstructured":"Juweid ME, Stroobants S, Hoekstra OS, Mottaghy FM, Dietlein M, Guermazi A, et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol. 2007;25(5):571\u20138.","journal-title":"J Clin Oncol"},{"issue":"5","key":"2825_CR21","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s00259-012-2079-y","volume":"39","author":"E Lopci","year":"2012","unstructured":"Lopci E, Zanoni L, Chiti A, Fonti C, Santi I, Zinzani PL, et al. FDG PET\/CT predictive role in follicular lymphoma. Eur J Nucl Med Mol Imaging. 2012;39(5):864\u201371. doi: 10.1007\/s00259-012-2079-y .","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"2825_CR22","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1007\/s00259-010-1539-5","volume":"37","author":"L Dortz Le","year":"2010","unstructured":"Le Dortz L, De Guibert S, Bayat S, Devillers A, Houot R, Rolland Y, et al. Diagnostic and prognostic impact of 18\u00a0F-FDG PET\/CT in follicular lymphoma. Eur J Nucl Med Mol Imaging. 2010;37(12):2307\u201314. doi: 10.1007\/s00259-010-1539-5 .","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"2825_CR23","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/108497803322287646","volume":"18","author":"N D\u00f6bert","year":"2003","unstructured":"D\u00f6bert N, Menzel C, Gr\u00fcnwald F. Positron emission tomography in patients with Hodgkin\u2019s disease: correlation to histopathologic subtypes. Cancer Biother Radiopharm. 2003;18(4):565\u201371.","journal-title":"Cancer Biother Radiopharm"},{"issue":"3","key":"2825_CR24","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/hon.782","volume":"24","author":"M Hutchings","year":"2006","unstructured":"Hutchings M, Loft A, Hansen M, Ralfkiaer E, Specht L. Different histopathological subtypes of Hodgkin lymphoma show significantly different levels of FDG uptake. Hematol Oncol. 2006;24(3):146\u201350.","journal-title":"Hematol Oncol"},{"issue":"1","key":"2825_CR25","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3324\/haematol.11661","volume":"93","author":"C Ansquer","year":"2008","unstructured":"Ansquer C, Hervou\u00ebt T, Devillers A, de Guibert S, Gastinne T, Le Gouill S, et al. 18-F FDG-PET in the staging of lymphocyte-predominant Hodgkin's disease. Haematologica. 2008;93(1):128\u201331. doi: 10.3324\/haematol.11661 .","journal-title":"Haematologica"},{"issue":"21","key":"2825_CR26","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1200\/JCO.2005.12.072","volume":"23","author":"H Sch\u00f6der","year":"2005","unstructured":"Sch\u00f6der H, Noy A, G\u00f6nen M, Weng L, Green D, Erdi YE, et al. Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin\u2019s lymphoma. J Clin Oncol. 2005;23(21):4643\u201351.","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"2825_CR27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/annonc\/13.S1.44","volume":"13","author":"T R\u00fcdiger","year":"2002","unstructured":"R\u00fcdiger T, Gascoyne RD, Jaffe ES, de Jong D, Delabie J, De Wolf-Peeters C, et al. Workshop on the relationship between nodular lymphocyte predominant Hodgkin\u2019s lymphoma and T cell\/histiocyte-rich B cell lymphoma. Ann Oncol. 2002;13 Suppl 1:44\u201351.","journal-title":"Ann Oncol"},{"issue":"3","key":"2825_CR28","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/cncr.24819","volume":"116","author":"I Biasoli","year":"2010","unstructured":"Biasoli I, Stamatoullas A, Meignin V, Delmer A, Reman O, Morschhauser F, et al. Nodular, lymphocyte-predominant Hodgkin lymphoma: a long-term study and analysis of transformation to diffuse large B-cell lymphoma in a cohort of 164 patients from the Adult Lymphoma Study Group. Cancer. 2010;116(3):631\u20139.","journal-title":"Cancer"},{"issue":"6","key":"2825_CR29","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/COC.0b013e318145b9db","volume":"30","author":"BS Chera","year":"2007","unstructured":"Chera BS, Olivier K, Morris CG, Lynch JW, Mendenhall NP. Clinical presentation and outcomes of lymphocyte-predominant Hodgkin disease at the University of Florida. Am J Clin Oncol. 2007;30(6):601\u20136.","journal-title":"Am J Clin Oncol"},{"issue":"Suppl s66","key":"2825_CR30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1600-0609.2005.00462.x","volume":"75","author":"L Nogov\u00e1","year":"2005","unstructured":"Nogov\u00e1 L, Reineke T, Josting A, M\u00fcller-Hermelink HK, Eich HT, Behringer K, et al. Lymphocyte-predominant and classical Hodgkin's lymphoma \u2013 comparison of outcomes. Eur J Haematol. 2005;75 Suppl s66:106\u2013110.","journal-title":"Eur J Haematol"},{"issue":"9","key":"2825_CR31","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1182\/blood-2004-02-0567","volume":"104","author":"P Feugier","year":"2004","unstructured":"Feugier P, Labouyrie E, Djeridane M, Jenabian A, Dubruille V, Berthou C, et al. Comparison of initial characteristics and long-term outcome of patients with lymphocyte-predominant Hodgkin lymphoma and classical Hodgkin lymphoma at clinical stages IA and IIA prospectively treated by brief anthracycline-based chemotherapies plus extended high-dose irradiation. Blood. 2004;104(9):2675\u201381.","journal-title":"Blood"},{"issue":"3-4","key":"2825_CR32","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3109\/10428199709051786","volume":"26","author":"E Orlandi","year":"1997","unstructured":"Orlandi E, Lazzarino M, Brusamolino E, Paulli M, Astori C, Magrini U, et al. Nodular lymphocyte predominance Hodgkin\u2019s disease: long-term observation reveals a continuous pattern of recurrence. Leuk Lymphoma. 1997;26(3-4):359\u201368.","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"2825_CR33","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1182\/blood-2002-08-2644","volume":"101","author":"BC Ekstrand","year":"2003","unstructured":"Ekstrand BC, Lucas JB, Horwitz SM, Fan Z, Breslin S, Hoppe RT, et al. Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial. Blood. 2003;101(11):4285\u20139.","journal-title":"Blood"},{"issue":"11","key":"2825_CR34","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.ejca.2011.10.018","volume":"48","author":"A Shankar","year":"2012","unstructured":"Shankar A, Hall GW, Gorde-Grosjean S, Hasenclever D, Leblanc T, Hayward J, et al. Treatment outcome after low intensity chemotherapy [CVP] in children and adolescents with early stage nodular lymphocyte predominant Hodgkin\u2019s lymphoma \u2013 an Anglo-French collaborative report. Eur J Cancer. 2012;48(11):1700\u20136.","journal-title":"Eur J Cancer"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-014-2825-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-014-2825-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-014-2825-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T18:44:51Z","timestamp":1565549091000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-014-2825-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,26]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["2825"],"URL":"https:\/\/doi.org\/10.1007\/s00259-014-2825-4","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,26]]}}}